Image
Pregnant individuals require routine, dedicated care to ensure positive parental and fetal outcomes.
GLP-1 medications are FDA-approved specifically for weight loss for more than half the adult population of the United States. Plan sponsors can take action to manage weight and other cardiodiabesity-related health challenges within their member population.
A report from the Evernorth Research Institute offers insights that can help health plans optimize cancer care.